The French Blood Establishment (EFS) confirmed the incident on Tuesday, saying its own systems had not been directly targeted. Safeguards prevented any loss of blood products. The affected equipment stored blood samples and frozen plasma, including plasma intended for transfusion.
"The EFS' monitoring and alarm systems enabled the rapid identification of these anomalies and the implementation of necessary measures to make sure that no blood samples or products were compromised," it said. "Thus, depending on the circumstances, as soon as the incident occurred, the affected equipment was either brought under control without impacting the products and samples, or neutralized; the products stored in these cold rooms were preventively transferred to other facilities." The EFS did not name the supplier publicly.
